Journalists and editors seldom highlight errors and misjudgements by other members of their trade. An exception was The Guardian's story on 1 October headed "Media accused of scaremongering on cancer jab death" and subtitled "Coverage causing more harm than good". The case at issue was that of a 14-year old Coventry schoolgirl who had died a few days previously, after receiving human papilloma virus (HPV) vaccine to prevent cervical cancer.
The criticism was apposite, as many newspaper, radio and TV reporters had failed to exercise caution in linking the vaccine causally with the fatality. Some had also alleged that HPV immunisation had been suspended around the UK.
Initial press coverage of the incident, even when it mentioned uncertainty about the cause of death, illustrated the disproportionate impact of headlines. "Girl of 14 dies after cervical cancer jab" said a Daily Mirror headline (29 September) occupying more space on the page than the report below. "Rogue cervical cancer jab fears after girl, 14, dies. Authorities seize suspect vaccine batch," announced the Daily Mail on the same day.
The Daily Mirror focused on human interest ("Everyone was panicking… It's really scary") with one cautionary sentence at the very end: "Health officials last night stressed that there was not yet any evidence that the jab was responsible for Natalie's death". The Guardian was particularly careful, reporting a Coventry city council official's view that "no link can be made between the death and the vaccine until all the facts are known and a post mortem takes place."
Next day, however, the Daily Mail devoted three pages to the story, heralded by a front-page banner headline 'Chaos Over Cancer Jab For Girls', and asserting that many health trusts throughout the country were cancelling vaccinations. There were similar assertions elsewhere, coupled with reports of anxieties among public health authorities that growing alarm might adversely affect immunisation campaigns against swine flu and other infections. The Daily Mirror produced a huge, self-defeating 'DON'T PANIC' headline, accompanied by a picture of tributes to Natalie pinned to a wooden cross and comments such as "we could be harming a whole generation of teenage girls" from a Birmingham mother.
Some of the unhelpful coverage was by writers ostensibly seeking to be helpful. The Independent (30 September) provided a mostly well-informed page of answers to the question "Is the cervical cancer vaccine safe, and should girls stop taking it?" But a summary box had three bullet points in favour and three against, implying that the arguments were evenly balanced.
Even commentators who should have known better were unwilling to wait for a post mortem. "The sudden death of Coventry schoolgirl Natalie Morton after a jab against cervical cancer highlights the reality that vaccination programmes are not without their risks," wrote Dr Richard Halvorsen in the Daily Mail. Lambasting "evangelists for mass vaccination", Halvorsen argued that "the tragic irony for Natalie was that Mediawatch: Bernard Dixon looks at the reaction to the death of a young girl after a routine HPV vaccination.
A jab at reality
Protection: One young British girl receives a now routine HPV vaccination. (Photo: Paula Solloway/Alamy.) the injection may have triggered a reaction far more lethal than any future distant threat of a comparatively rare disease".
The Health Editor of The Times, alongside sound advice under the headline "There are always risks, but this vaccine will save lives", strongly implied that HPV vaccine had caused Natalie's death. "Most experts agree that vaccinating against the virus that causes cervical cancer is a good thing," he wrote. "It carries risks, as fatally shown in Coventry, but these are outweighed by benefits. Getting this across is far from easy. An unknown life saved decades down the line does not capture the imagination like the spectre on a young life lost."
Equally surprising was an article in The Daily Telegraph (30 September) by a researcher at the Wellcome Trust Centre for the History of Medicine, London. "Politicians have long known that a life lost today is far more emotive than a life saved in some hard-to-glimpse future," Mark Honigsbaum wrote. "Never mind that history is pitted with examples of vaccines that the public was falsely assured were safe: the experts reason that in every mass vaccination there are bound to be a few casualties." Parents were entitled to weigh for themselves the risks of protecting their daughters by HPV vaccination, he said, "but there are also other methods, such as better screening". The latter comment was particularly inept, since regular screening will continue for many years and is in no sense an alternative to immunisation.
In its article on 1 October, The Guardian pointed out that vaccination programmes had not been suspended (there had simply been a slight delay in certain areas receiving vaccine supplies), and that a "serious underlying medical condition" was probably responsible for Natalie Morton's death. Next day, nearly all newspapers and radio and TV channels carried the pathologist's finding of a "large malignant tumour of unknown origin in the heart and lungs".
The immediate furore -though probably not underlying public anxiety -was at an end.
Bernard Dixon is the European editor of the American Association for Microbiology.
After considerable public and parliamentary debate in the UK that backed the creation of human-animal hybrid embryonic stem cells for research purposes, given the shortage of human-derived cells, research involving them currently appears to have been refused funding.
All three projects to develop embryonic stem cells from cloned embryos created by fusing human cells with animal cells have been stalled, after publicly-funded research councils refused to fund research involving the hybrid cells in this year's grant applications.
Two of the projects failed to win funds earlier this year and the third is now understood to have ended when a funding application was withdrawn after the research licence issued by the Human Fertilisation and Embryology Authority (HFEA), responsible for such research, expired during the summer without being renewed, The Independent newspaper reported.
Plans to allow British scientists to create human-animal embryos were approved in 2007 by the HFEA after it published its lengthy public consultation document. It found that the majority of people were 'at ease' with scientists creating the hybrid embryos.
The new Human Fertilisation and Embryology Act, which came into force last month, was specifically amended to permit the creation of cloned Britain's support for human-animal stem cell research seems to be faltering. Nigel Williams reports.
Stemmed cells
Challenge: The UK's support for embryonic stem cell research appears to be changing. (Picture: R. Yorgos Nikas/Science Photo Library.)
